Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer

Rensi Marco, Ferretti Guido, Di Gregorio Fernando, Evangelista Laura

Research output: Contribution to journalArticle

Abstract

A 73-year-old man with a prostate cancer treated by radical prostatectomy in 2006. For a biochemical recurrence of disease (prostate-specific antigen level, 0.1 ng/mL) during hormonal therapy, patient underwent F-choline PET/CT that showed a significant uptake in a diffuse right pleural thickening. The patient was sent to pleurectomy decortication showing an epithelioid pleural mesothelioma. This case highlighted that a histopathological evaluation is mandatory in case of a significant radiolabeled choline uptake in pleural lesions.

Original languageEnglish
Pages (from-to)e116-e117
JournalClinical Nuclear Medicine
Volume44
Issue number2
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Mesothelioma
Choline
Prostatic Neoplasms
Recurrence
Prostate-Specific Antigen
Prostatectomy
fluoromethylcholine
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer. / Marco, Rensi; Guido, Ferretti; Fernando, Di Gregorio; Laura, Evangelista.

In: Clinical Nuclear Medicine, Vol. 44, No. 2, 01.02.2019, p. e116-e117.

Research output: Contribution to journalArticle

@article{bfedad6c024c47afbefdf4062dcb7e39,
title = "Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer",
abstract = "A 73-year-old man with a prostate cancer treated by radical prostatectomy in 2006. For a biochemical recurrence of disease (prostate-specific antigen level, 0.1 ng/mL) during hormonal therapy, patient underwent F-choline PET/CT that showed a significant uptake in a diffuse right pleural thickening. The patient was sent to pleurectomy decortication showing an epithelioid pleural mesothelioma. This case highlighted that a histopathological evaluation is mandatory in case of a significant radiolabeled choline uptake in pleural lesions.",
author = "Rensi Marco and Ferretti Guido and Fernando, {Di Gregorio} and Evangelista Laura",
year = "2019",
month = "2",
day = "1",
doi = "10.1097/RLU.0000000000002416",
language = "English",
volume = "44",
pages = "e116--e117",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer

AU - Marco, Rensi

AU - Guido, Ferretti

AU - Fernando, Di Gregorio

AU - Laura, Evangelista

PY - 2019/2/1

Y1 - 2019/2/1

N2 - A 73-year-old man with a prostate cancer treated by radical prostatectomy in 2006. For a biochemical recurrence of disease (prostate-specific antigen level, 0.1 ng/mL) during hormonal therapy, patient underwent F-choline PET/CT that showed a significant uptake in a diffuse right pleural thickening. The patient was sent to pleurectomy decortication showing an epithelioid pleural mesothelioma. This case highlighted that a histopathological evaluation is mandatory in case of a significant radiolabeled choline uptake in pleural lesions.

AB - A 73-year-old man with a prostate cancer treated by radical prostatectomy in 2006. For a biochemical recurrence of disease (prostate-specific antigen level, 0.1 ng/mL) during hormonal therapy, patient underwent F-choline PET/CT that showed a significant uptake in a diffuse right pleural thickening. The patient was sent to pleurectomy decortication showing an epithelioid pleural mesothelioma. This case highlighted that a histopathological evaluation is mandatory in case of a significant radiolabeled choline uptake in pleural lesions.

UR - http://www.scopus.com/inward/record.url?scp=85059497182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059497182&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000002416

DO - 10.1097/RLU.0000000000002416

M3 - Article

C2 - 30516662

AN - SCOPUS:85059497182

VL - 44

SP - e116-e117

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 2

ER -